FEED (ENvue Medical) Defensive Interval Ratio


FEED ENvue Medical Inc FEED
37 GF Score
Price $0.52
GF Value $5.13
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is ENvue Medical Defensive Interval Ratio?

FEED
37GF Score
ENvue Medical Inc FEED
Defensive Interval Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is ENvue Medical (FEED) Overvalued in 2026?

Based on GuruFocus' analysis, ENvue Medical stock appears to be undervalued. The current stock price of $0.52 is trading 89.8% below its estimated GF Value™ of $5.13. GuruFocus considers ENvue Medical to be Possible Value Trap.

Key valuation signals for FEED:

  • Defensive Interval Ratio:
  • GF Value™: $5.13 vs. price of $0.52 (89.8% below fair value)
  • GF Score™: 37/100 with 4 warning signs

No single metric tells the full story. See the FEED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ENvue Medical Business Description

Address 969 Pruitt Avenue, Tyler, TX, USA, 77569
ENvue Medical Inc develops medical devices for enhanced navigation in clinical procedures. The company provides personalized navigation technology to assist clinicians in placing feeding tubes safely and efficiently. Its ENvue system uses smart feeding tubes with sensors, body mapping, and continuous visual guidance to confirm accurate positioning and reduce complications like lung misplacement. The company conducted the business through two primary operating segments: NanoVibronix and ENvue. The firm generates the majority of its revenue from NanoVibronix, which derives revenues from selling its products directly to patients as well as through distributor agreements. ENvue derives revenues from selling its Systems and Nasoenteral tubes.
37GF Score

Get the complete analysis for FEED

Defensive Interval Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.52
Price
$5.13
GF Value